Found: 22
Select item for more details and to access through your institution.
Correction: Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Author Correction: Chemosensitivity profiling of osteosarcoma tumour cell lines identifies a model of BRCAness.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1A.
- Published in:
- Nature Communications, 2016, v. 7, n. 12, p. 13837, doi. 10.1038/ncomms13837
- By:
- Publication type:
- Article
Resistance to therapy caused by intragenic deletion in BRCA2.
- Published in:
- Nature, 2008, v. 451, n. 7182, p. 1111, doi. 10.1038/nature06548
- By:
- Publication type:
- Article
Pathway-based signatures predict patient outcome, chemotherapy benefit and synthetic lethal dependencies in invasive lobular breast cancer.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 11, p. 1828, doi. 10.1038/s41416-024-02679-7
- By:
- Publication type:
- Article
Genome-wide and high-density CRISPR-Cas9 screens identify point mutations in PARP1 causing PARP inhibitor resistance.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-03917-2
- By:
- Publication type:
- Article
Cancer‐associated FBXW7 loss is synthetic lethal with pharmacological targeting of CDC7.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 2, p. 369, doi. 10.1002/1878-0261.13537
- By:
- Publication type:
- Article
Synthetic lethality of PARP and NAMPT inhibition in triple-negative breast cancer cells.
- Published in:
- EMBO Molecular Medicine, 2012, v. 4, n. 10, p. 1087, doi. 10.1002/emmm.201201250
- By:
- Publication type:
- Article
Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors.
- Published in:
- EMBO Molecular Medicine, 2009, v. 1, n. 6/7, p. 315, doi. 10.1002/emmm.200900041
- By:
- Publication type:
- Article
A Genetic Screen Using the PiggyBac Transposon in Haploid Cells Identifies <i>Parp1</i> as a Mediator of Olaparib Toxicity.
- Published in:
- PLoS ONE, 2013, v. 8, n. 4, p. 1, doi. 10.1371/journal.pone.0061520
- By:
- Publication type:
- Article
Targeting p90 Ribosomal S6 Kinase Eliminates Tumor-Initiating Cells by Inactivating Y-Box Binding Protein-1 in Triple-Negative Breast Cancers.
- Published in:
- Stem Cells, 2012, v. 30, n. 7, p. 1338, doi. 10.1002/stem.1128
- By:
- Publication type:
- Article
Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer.
- Published in:
- Nature, 2013, v. 493, n. 7432, p. 406, doi. 10.1038/nature11725
- By:
- Publication type:
- Article
APRIN is a cell cycle specific BRCA2-interacting protein required for genome integrity and a predictor of outcome after chemotherapy in breast cancer.
- Published in:
- EMBO Journal, 2012, v. 31, n. 5, p. 1160, doi. 10.1038/emboj.2011.490
- By:
- Publication type:
- Article
A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor.
- Published in:
- EMBO Journal, 2008, v. 27, n. 9, p. 1368, doi. 10.1038/emboj.2008.61
- By:
- Publication type:
- Article
Sirtuin inhibition is synthetic lethal with BRCA1 or BRCA2 deficiency.
- Published in:
- Communications Biology, 2021, v. 4, n. 1, p. 1, doi. 10.1038/s42003-021-02770-2
- By:
- Publication type:
- Article
Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours.
- Published in:
- 2017
- By:
- Publication type:
- Correction Notice
Stringent and reproducible tetracycline-regulated transgene expression by site-specific insertion at chromosomal loci with pre-characterised induction characteristics.
- Published in:
- BMC Molecular Biology, 2007, v. 8, p. 30, doi. 10.1186/1471-2199-8-30
- By:
- Publication type:
- Article
Cross-platform pathway-based analysis identifies markers of response to the PARP inhibitor olaparib.
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 135, n. 2, p. 505, doi. 10.1007/s10549-012-2188-0
- By:
- Publication type:
- Article
Functional characterization of protein variants of the human multidrug transporter ABCC2 by a novel targeted expression system in fibrosarcoma cells.
- Published in:
- Human Mutation, 2012, v. 33, n. 4, p. 750, doi. 10.1002/humu.22041
- By:
- Publication type:
- Article
The Dual Mechanisms of Cognitive Control dataset, a theoretically-guided within-subject task fMRI battery.
- Published in:
- Scientific Data, 2022, v. 9, n. 1, p. 1, doi. 10.1038/s41597-022-01226-4
- By:
- Publication type:
- Article
Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours.
- Published in:
- 2016
- By:
- Publication type:
- Correction Notice
CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours.
- Published in:
- PLoS ONE, 2016, v. 11, n. 2, p. 1, doi. 10.1371/journal.pone.0149099
- By:
- Publication type:
- Article